Serum VEGF and b-FGF profiles after tension-free or conventional hernioplasty

Langenbeck's Archives of Surgery

Volumn 390, Issue 6, 2005, Pages 528-533

  Di Vita, Gaetano ^a   Patti, Rosalia ^a   D'Agostino, Pietro ^a   Arcoleo, Francesco ^b   Caruso, Giuseppe ^b   Arcara, Matteo ^a   Davì, Valentina ^a   Cillari, Enrico ^b  

^a UNIVERSITY OF PALERMO   (Italy)

^b VILLA SOFIA CERVELLO HOSPITAL   (Italy)

Author keywords

b FGF; Hernioplasty; IFN ; IL 10; Mesh; VEGF

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; GAMMA INTERFERON; INTERLEUKIN 10; POLYPROPYLENE; VASCULOTROPIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HERNIOPLASTY; HUMAN; INGUINAL HERNIA; MALE; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN SYNTHESIS; RANDOMIZED CONTROLLED TRIAL; SURGICAL TECHNIQUE;

ADULT; ANALYSIS OF VARIANCE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FIBROBLAST GROWTH FACTOR 2; HERNIA, INGUINAL; HUMANS; INTERFERON TYPE II; INTERLEUKIN-10; MALE; MIDDLE AGED; STATISTICS, NONPARAMETRIC; SURGICAL MESH; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 27744567584     PISSN: 14352443     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00423-005-0578-z     Document Type: Article

References (37)

1. Schumpelik V, Klinge U, Welty G, Klosterhalfen B (1999) Meshes within the abdominal wall. Chirurg 70:876-887
2. Schachtrupp A, Klinge U, Junge K, Rosch R, Bhardwaj RS, Schumpelick V (2003) Individual inflammatory response of human blood monocytes to mesh biomaterials. Br J Surg 90:114-120
3. Di Vita G, Milano S, Frazzetta M, Patti R, Palazzolo V, Barbera C, Ferlazzo V, Leo P, Cillari E (2000) Tension-free hernia repair is associated with an increase in inflammatory response markers against the mesh. Am J Surg 180:203-207
4. Di Vita G, Milano S, Patti R, Raimondo D, Di Bella G, D'Agostino P, Leo P, Cillari E (2001 ) Cytokine modifications after tension-free hernioplasty or open conventional inguinal hernia repair. Am J Surg 181:487-491
5. Walker AP (1995) Biomaterials in hernia repair. In: Nyhus LM, Condon RE (eds) Hernia, 4th edn. JB Lippincott, Philadelphia, pp 534-540
6. Howdieshell TR, Callaway D, Webb WL, Gaines MD, Procter CD Jr, Sathyanarayana, Pollock JS, Brock TL, McNeil PL (2001) Antibody neutralization of vascular endothelial growth factor inhibits wound granulation tissue formation. J Surg Res 96:173-182
7. Amoroso A, Del Porto F, Di Monaco C, Manfredini P, Afeltra A (1997) Vascular endothelial growth factor: a key mediator of angiogenesis. A review. Eur Rev Med Pharmacol Sci 1:17-25
8. Karayiannakis AJ, Zbar A, Polychronidis A, Simopoulos C (2003) Serum and drainage fluid vascular endothelial growth factor levels in early surgical wounds. Eur Surg Res 35:492-496
9. Pakala R, Watanabe T, Benedict CR (2002) Induction of endothelial cell proliferation by angiogenic factors released by activated monocytes. Cardiovasc Radiat Med 3:95-101
10. Belgore F, Lip GY, Blann AD (2003) Basic fibrobrast growth factor induces the secretion of vascular endothelial growth factor by human aortic smooth muscle cells but not by endothelial cells. Eur J Clin Investig 33:833-839
11. Junge K, Klinge U, Klosterhalfen B, Mertens PR, Rosch R, Schachtrupp A, Ulmer F, Schumpelick V (2002) Influence of mesh materials on collagen deposition in a rat model. J Invest Surg 15:319-328
12. Rumalla VK, Borah GL (2001) Cytokines, growth factors, and plastic surgery. Plast Reconstr Surg 108:719-733
13. Dans MJ, Isseroff RJ (1994) Inhibition of collagen lattice contraction by pentoxifylline and interferon-alpha, -beta, and -gamma. Invest Dermatol 102:118-121
14. Tredget EE, Wang R, Shen Q, Scott PG, Ghahary A (2000) Transforming growth factor-beta mRNA and protein in hypertrophic scar tissues and fibroblasts: antagonism by IFN-alpha and IFN-gamma in vitro and in vivo. J Interferon Cytokine Res 20:143-151
15. Castagnoli C, Stella M, Magliacani G (2002) Role of T-lymphocytes and cytokines in post-burn hypertrophic scars. Wound Repair Regen 10:107-108
16. Miles RH, Paxton TP, Zacheis D, Dries DJ, Gamelli RL (1994) Systemic administration of interferon-gamma impairs wound healing. J Surg Res 56:288-294
17. Broker BJ, Rosen D, Amsberry J, Schmidt R, Sailor L, Pribitkin EA, Keane WM (1996) Keloid excision and recurrence prophylaxis via intradermal interferon-gamma injections: a pilot study. Laryngoscope 106:1497-1501
18. Sato Y, Ohshima T, Kondo T (1999) Regulatory role of endogenous interleukin-10 in cutaneous inflammatory response of murine wound healing. Biochem Biophys Res Commun 265:194-199
19. Rennick DM, Fort MM, Davidson NJ (1997) Studies with IL-10-/- mice: an overview. J Leukoc Biol 61:389-396
20. Liechty KW, Kim HB, Adzick NS, Crombleholme TM (2000) Fetal wound repair results in scar formation in interleukin-10-deficient mice in a syngeneic murine model of scarless fetal wound repair. J Pediatr Surg 35:866-872
21. de Waal Malefyt R, Abrams J, Bennett B, Figdor GC, de Vries JE (1991) Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an auto regulatory role of IL-10 produced by monocyte. J Exp Med 174:1209-1220
22. Lundberg JE, Roth TP, Dunn RM, Doyle JW (1998) Comparison of IL-10 levels in chronic venous insufficiency ulcers and autologous donor tissue. Arch Dermatol Res 290:669-673
23. Amid PK, Shulman AG, Lichtenstein IL (1996) Open "tension-free" repair of inguinal hernias: the Lichtenstein technique. Eur J Surg 162:447-453
24. Bassini E (1893) Nuovo metodo operative per la cura radicale dell'ernia crurale. Angelo Draghi Libraio Ed, Padova
25. Nyhus LM (1993) Individualisation of hernia repair: a new era. Surgery 114:1-2
26. American Society of Anesthesiologists (1963) New classification of physiology status. Anesthesiology 24:111
27. Jain RK (2003) Molecular regulation of vessel maturation. Nat Med 9:685-693
28. Howdieshell TR, Webb WL, Sathyanarayana, McNeil PL (2003) Inhibition of inducible nitric oxide synthase results in reductions in wound vascular endothelial growth factor expression, granulation tissue formation, and local perfusion. Surgery 133:528-537
29. Koch AE (1998) Angiogenesis. Implications for rheumatoid arthritis. Arthritis Rheum 41:951-962
30. Ballara SC, Miotla JM, Paleolog EM (1999) New vessels, new approaches: angiogenesis as a therapeutic target in musculoskeletal disorders. Int J Exp Pathol 80:235-250
31. Cross MJ, Claesson-Welsh L (2002) FGF and VEGF function in angiogenesis; signalling pathways, biological responses and therapeutic inhibition. TIPS 22:201-207
32. Trompezinski S, Denis A, Vinche A, Schmitt D, Viac J (2002) IL-4 and interferon-gamma differentially modulate vascular endothelial growth factor release from normal human keratinocytes and fibroblasts. Exp Dermatol 11:224-231
33. Wei LH, Kuo ML, Chen CA, Chou CH, Cheng WF, Chang MC, Su JL, Hsieh CY (2001) Interleukin-6 in cervical cancer: the relationship with vascular endothelial growth factor. Gynecol Oncol 82:49-56
34. Cornelissen AM, Maltha JC, Von den Hoff JW, Kuijpers-Jagtman AM (2000) Local injection of IFN-gamma reduces the number of myofibroblasts and the collagen content in palatal wounds. Dent Res 79:1782-1788
35. Renauld JC (2003) Class II cytokine receptors and their ligands: key antiviral and inflammatory modulators. Nat Rev Immunol 3:667-676
36. O'Riordan DC, Morgan M, Kingsnorth AN (1998) The surgical management of inguinal hernia in England. Hernia 2:S 17
37. Vrijland WW, van den Tol MP, Luijendijk RW, Hop WC, Busschbach JJ, de Lange DC, van Geldere D, Rottier AB, Vegt PA, Ijzermans JN, Jeekel J (2002) Randomized clinical trial of non-mesh versus mesh repair of primary inguinal hernia. Br J Surg 89:293-297